Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Kyla Driscoll

Targeting the TGFβ Pathway With Galunisertib, a TGFβRI SMI, Promotes Anti-Tumor Immunity Leading to Durable, Complete Responses, as Monotherapy and in Combination With Checkpoint Inhibition

Journal for ImmunoTherapy of Cancer

English

A Phase 1 Study of Anti-TGFβ Receptor Type-Ii Monoclonal Antibody LY3022859 in Patients With Advanced Solid Tumors

Cancer Chemotherapy and Pharmacology

English

Related publications

Anti-Nkg2a mAb Is a Checkpoint Inhibitor That Promotes Anti-Tumor Immunity by Unleashing Both T and NK Cells

English

Combining Anti-Ctla4 With RG7787, an Immunotoxin Targeting Mesothelin, Promotes Tumor Eradication

Journal for ImmunoTherapy of Cancer

English

Targeting NKT Cells and PD-L1 Pathway Results in Augmented Anti-Tumor Responses in a Melanoma Model

Cancer Immunology, Immunotherapy

English

Chemoradiation Combined With Phosphatidylserine-Targeting Antibody Enhances Systemic Anti-Tumor Immune Responses

International Journal of Radiation Oncology Biology Physics

English

Schweinfurthin Natural Products Induce Regression of Murine Melanoma and Pair With Anti-Pd-1 Therapy to Facilitate Durable Tumor Immunity

English

Targeting PIM Kinase With PD1 Inhibition Improves Immunotherapeutic Anti-Tumor T Cell Response

Clinical Cancer Research

Cancer Research

Oncology

2019

English

Copanlisib in Combination With Anti-Pd-1 Induces Regression in Animal Tumor Models Insensitive or Resistant to the Monotherapies of Pi3k and Checkpoint Inhibitors

Hematological Oncology

English

Inhibition of Ataxia-Telangiectasia Mutated and RAD3-related (ATR) Overcomes Oxaliplatin Resistance and Promotes Anti-Tumor Immunity in Colorectal Cancer.

Cancer Research

Oncology

2019

English

TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination With Anti-Pd1 and Anti-Cd137 Immunostimulatory Monoclonal Antibodies

Molecular Cancer Therapeutics

Cancer Research

Oncology

2019

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Kyla Driscoll

Targeting the TGFβ Pathway With Galunisertib, a TGFβRI SMI, Promotes Anti-Tumor Immunity Leading to Durable, Complete Responses, as Monotherapy and in Combination With Checkpoint Inhibition

A Phase 1 Study of Anti-TGFβ Receptor Type-Ii Monoclonal Antibody LY3022859 in Patients With Advanced Solid Tumors

Related publications

Anti-Nkg2a mAb Is a Checkpoint Inhibitor That Promotes Anti-Tumor Immunity by Unleashing Both T and NK Cells

Combining Anti-Ctla4 With RG7787, an Immunotoxin Targeting Mesothelin, Promotes Tumor Eradication

Targeting NKT Cells and PD-L1 Pathway Results in Augmented Anti-Tumor Responses in a Melanoma Model

Chemoradiation Combined With Phosphatidylserine-Targeting Antibody Enhances Systemic Anti-Tumor Immune Responses

Schweinfurthin Natural Products Induce Regression of Murine Melanoma and Pair With Anti-Pd-1 Therapy to Facilitate Durable Tumor Immunity

Targeting PIM Kinase With PD1 Inhibition Improves Immunotherapeutic Anti-Tumor T Cell Response

Copanlisib in Combination With Anti-Pd-1 Induces Regression in Animal Tumor Models Insensitive or Resistant to the Monotherapies of Pi3k and Checkpoint Inhibitors

Inhibition of Ataxia-Telangiectasia Mutated and RAD3-related (ATR) Overcomes Oxaliplatin Resistance and Promotes Anti-Tumor Immunity in Colorectal Cancer.

TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination With Anti-Pd1 and Anti-Cd137 Immunostimulatory Monoclonal Antibodies